Urinary Tract Infection (UTI)
Summary
Urinary tract infection (UTI) is bacterial infection of the urinary tract, divided into lower UTI (cystitis - bladder) and upper UTI (pyelonephritis - kidney). It is one of the most common infections in clinical practice, affecting 50% of women at some point in their lives. Escherichia coli causes 70-90% of community-acquired UTIs. Management depends on classification as uncomplicated or complicated, patient factors, and local resistance patterns. [1,2]
Key Facts
- Incidence: 150 million cases globally per year. [3]
- Lifetime Risk (Women): 50-60%; 25% will have recurrence.
- Common Organism: E. coli (70-90% of uncomplicated UTI).
- Classification: Lower (cystitis) vs Upper (pyelonephritis); Uncomplicated vs Complicated.
- Diagnosis: Clinical symptoms + dipstick (nitrites/leucocytes) ± culture.
- Treatment: Short-course antibiotics for uncomplicated; longer courses for complicated/pyelonephritis.
Clinical Pearls
Nitrites = Gram-Negative Bacteria: Only organisms that reduce nitrate to nitrite (mainly Enterobacteriaceae) give positive nitrite. A negative nitrite does NOT exclude infection (Staph saprophyticus, Enterococcus don't produce nitrite).
Leucocyte Esterase Alone is Non-Specific: Positive leucocytes can occur with sterile pyuria (STI, TB, stones, interstitial nephritis). Send MSU if in doubt.
UTI in Men is Always Complicated: Men have longer urethras and prostatic antibacterial factors. Any UTI should prompt investigation for underlying cause (residual volume, prostate).
Asymptomatic Bacteriuria - When to Treat: ONLY treat in pregnancy and before urological procedures. Do NOT treat in elderly, catheterised, diabetics, or institutionalised patients (no benefit, drives resistance). [4]
Incidence and Demographics
- Global Burden: 150+ million UTIs annually.
- Women: Annual incidence 10-15%; lifetime risk 50-60%.
- Men: Annual incidence less than 1% under 50 years; increases with age (prostatic disease).
- Peak Age in Women: Young sexually active (18-24) and postmenopausal.
- Children: 3-5% of girls, 1% of boys by age 10.
Risk Factors
Women
| Risk Factor | Mechanism |
|---|---|
| Female anatomy | Short urethra, proximity to anus |
| Sexual activity | "Honeymoon cystitis"; mechanical introduction |
| Spermicide use | Alters vaginal flora |
| New sexual partner | Different bacterial exposure |
| Pregnancy | Ureteric dilation, stasis, immunological changes |
| Menopause | Oestrogen deficiency → ↓Lactobacilli |
| Previous UTI | Single strongest predictor of recurrence |
| Diabetes | Glycosuria, immune impairment |
| Urinary instrumentation | Catheters, cystoscopy |
Men
| Risk Factor | Mechanism |
|---|---|
| BPH/Prostatic enlargement | Incomplete emptying, residual volume |
| Prostatic disease | Bacterial reservoir |
| Urethral stricture | Obstruction, stasis |
| Catheterisation | Direct bacterial introduction |
| Uncircumcised | Slightly increased colonisation |
| Age greater than 50 | Prostatic factors |
Causative Organisms
| Organism | Frequency | Notes |
|---|---|---|
| Escherichia coli | 70-90% | Most common; gut commensal |
| Klebsiella pneumoniae | 5-10% | Complicated UTI |
| Proteus mirabilis | 5-10% | Produces urease → struvite stones |
| Staphylococcus saprophyticus | 5-15% (young women) | Does NOT produce nitrites |
| Enterococcus faecalis | 5% | Intrinsic resistance to cephalosporins |
| Pseudomonas aeruginosa | Hospital/catheter | Biofilm formation |
| Candida species | Catheterised, diabetic | Fungal; often colonisation |
Step 1: Bacterial Entry
- Ascending Route: Most common. Bacteria colonise periurethral area → ascend urethra → bladder.
- Haematogenous: Rare; seen with S. aureus bacteraemia → renal abscess.
- Lymphatic: Theoretical.
Step 2: Colonisation
- Bacterial Adherence: Fimbriae (pili) bind to uroepithelial receptors.
- Type 1 Fimbriae: Bind mannose; important for cystitis.
- P-Fimbriae: Bind P-blood group antigens; important for pyelonephritis.
- Biofilm Formation: Particularly on catheters.
Step 3: Host Response
- Innate Immunity: Urinary flow (washout), urine pH, antimicrobial peptides (defensins).
- PRR Activation: Toll-like receptors recognise LPS → cytokine release.
- Inflammation: Neutrophil recruitment → pyuria.
- Mucosal Damage: Dysuria, frequency, urgency.
Step 4: Cystitis vs Pyelonephritis
Cystitis (Lower UTI)
- Infection confined to bladder.
- Local symptoms only.
- No systemic involvement.
Pyelonephritis (Upper UTI)
- Bacteria ascend via ureters to kidney.
- Parenchymal infection.
- Systemic inflammatory response (fever, rigors).
- Risk of abscess, scarring, sepsis.
Step 5: Complicated vs Uncomplicated
| Uncomplicated | Complicated |
|---|---|
| Non-pregnant adult female | Pregnancy |
| Normal urinary tract anatomy | Structural abnormality |
| No systemic symptoms | Male |
| No immunocompromise | Catheter-associated |
| Diabetes | |
| Immunosuppression | |
| Recent instrumentation | |
| Children |
Lower UTI (Cystitis)
| Symptom | Frequency | Description |
|---|---|---|
| Dysuria | 80-90% | Burning/stinging on urination |
| Frequency | 80% | Passing urine more often |
| Urgency | 60% | Sudden need to urinate |
| Suprapubic pain | 50% | Lower abdominal discomfort |
| Haematuria | 40% | Visible or microscopic |
| Cloudy/offensive urine | 40% | Pyuria, bacteriuria |
| Nocturia | 30% | Night-time voiding |
Upper UTI (Pyelonephritis)
| Symptom | Frequency | Description |
|---|---|---|
| Fever | 90% | Often high (greater than 38°C), rigors |
| Loin/flank pain | 80% | Unilateral, may radiate |
| Nausea/vomiting | 50-60% | Unable to tolerate oral medications |
| Lower UTI symptoms | 50% | May or may not be present |
| Costovertebral angle tenderness | 80% | On examination |
Special Populations
Elderly
Children
Pregnancy
Red Flags - "The Don't Miss" Signs
- Fever, rigors, loin pain → Pyelonephritis; may need IV antibiotics.
- Signs of sepsis → Urgent assessment; IV antibiotics within 1 hour.
- Unable to tolerate oral intake → Admission for IV therapy.
- Retention with infection → Obstructed infected system; urology emergency.
- UTI in pregnancy → Higher risk of complications; requires culture.
- Recurrent UTI in men → Investigate for underlying cause.
General Assessment
- Temperature (fever suggests upper UTI/sepsis).
- Heart rate, blood pressure (sepsis assessment).
- Hydration status.
Abdominal Examination
- Suprapubic tenderness (cystitis).
- Loin tenderness, renal angle tenderness (pyelonephritis).
- Palpable bladder (retention).
- Abdominal mass (renal abscess).
Specific Tests
Costovertebral Angle (CVA) Tenderness
- Percussion over the flank at the angle of 12th rib and spine.
- Pain = suggests pyelonephritis.
Digital Rectal Examination (Men)
- Prostatic enlargement (BPH).
- Prostatic tenderness (prostatitis - avoid vigorous examination).
Pelvic Examination (If Indicated)
- Exclude vaginitis, STI.
- Particularly if dysuria without frequency.
Urinalysis
Urine Dipstick
| Parameter | Significance | Sensitivity | Specificity |
|---|---|---|---|
| Nitrites | Gram-negative organisms | 45-60% | 85-98% (high) |
| Leucocyte Esterase | Pyuria | 75-90% | 65-80% |
| Blood | May be present in UTI | Non-specific | Non-specific |
| Protein | May be present | Non-specific | Non-specific |
Interpretation
- Nitrites + Leucocytes: High probability of UTI; treat empirically.
- Nitrites alone: Supports UTI.
- Leucocytes alone: May be UTI or other cause (STI, contamination).
- Both negative: 96% NPV; unlikely UTI (but doesn't exclude).
Mid-Stream Urine (MSU) Culture
When to Send
| Indication | Rationale |
|---|---|
| All men | UTI in men is complicated |
| Pregnancy | Need to confirm eradication |
| Treatment failure | Resistance testing |
| Recurrent UTI | Confirm organism and sensitivity |
| Complicated UTI | Guide antibiotic choice |
| Pyelonephritis | Confirm organism |
| Catheterised | If symptomatic |
| Hospital-acquired | Higher resistance rates |
Culture Results
- Significant bacteriuria: at least 10⁵ CFU/mL (symptomatic at least 10³ may be significant).
- Mixed growth: Usually contamination; repeat if clinical concern.
Blood Tests (Pyelonephritis/Sepsis)
- FBC: Leucocytosis.
- U&E: Renal function.
- CRP: Elevated in pyelonephritis.
- Blood cultures: If febrile or septic.
- Lactate: If sepsis suspected.
Imaging (Selected Cases)
| Investigation | Indication |
|---|---|
| Renal ultrasound | Obstruction, abscess, failure to respond in 48-72 hours |
| CT urogram | Renal/perinephric abscess, stones |
| MCUG (children) | Vesicoureteric reflux investigation |
| Cystoscopy | Recurrent UTI, haematuria, bladder pathology |
Management Algorithm
SUSPECTED UTI
↓
┌────────────────────────────────────────┐
│ CLINICAL ASSESSMENT │
│ - Symptoms (dysuria, frequency, fever)│
│ - Risk factors (complicated?) │
│ - Red flags (sepsis, loin pain) │
└────────────────────────────────────────┘
↓
URINE DIPSTICK
↓
┌────────────┴────────────┐
↓ ↓
POSITIVE NEGATIVE
(Nitrites/Leucocytes) (Both negative)
↓ ↓
TREAT Consider alternative
diagnosis (STI, vaginitis)
↓ Repeat if high suspicion
↓
┌───┴───────────────────────────────┐
↓ ↓
UNCOMPLICATED COMPLICATED
(Healthy non-pregnant (Men, pregnancy,
woman) catheter, pyelonephritis)
↓ ↓
┌──────────────────┐ ┌──────────────────┐
│ - No MSU needed │ │ - SEND MSU │
│ - Short course │ │ - Longer course │
│ antibiotics │ │ - Consider │
│ - First-line: │ │ admission if │
│ Nitrofurantoin │ │ severe │
│ or Trimethoprim │ │ │
│ (3 days) │ │ │
└──────────────────┘ └──────────────────┘
Antibiotic Treatment
Acute Uncomplicated Cystitis in Women (NICE NG109) [5]
| Antibiotic | Dose | Duration | Notes |
|---|---|---|---|
| Nitrofurantoin | 100mg MR BD | 3 days | First-line; avoid if eGFR less than 45 |
| Trimethoprim | 200mg BD | 3 days | Check local resistance (greater than 30% in some areas) |
| Pivmecillinam | 400mg TDS | 3 days | Alternative |
| Fosfomycin | 3g single dose | Once | Alternative |
Pyelonephritis (Uncomplicated)
| Antibiotic | Dose | Duration | Notes |
|---|---|---|---|
| Cefalexin | 500mg BD-TDS | 7-10 days | First-line oral |
| Co-amoxiclav | 625mg TDS | 7-10 days | Alternative |
| Ciprofloxacin | 500mg BD | 7 days | If culture supports |
| IV options | Cefuroxime, Gentamicin | 7-14 days | If unable to tolerate oral/severe |
Complicated UTI (Men, Catheter, Structural)
| Antibiotic | Dose | Duration | Notes |
|---|---|---|---|
| Trimethoprim | 200mg BD | 7 days | After culture result |
| Nitrofurantoin | 100mg MR BD | 7 days | Only for lower UTI |
| Ciprofloxacin | 500mg BD | 7 days | Good prostate penetration |
UTI in Pregnancy [6]
| Antibiotic | Dose | Duration | Notes |
|---|---|---|---|
| Nitrofurantoin | 100mg BD | 7 days | Avoid at term (haemolytic anaemia) |
| Amoxicillin | 500mg TDS | 7 days | If sensitivity known |
| Cefalexin | 500mg BD | 7 days | Safe throughout pregnancy |
| Avoid | Trimethoprim (1st trimester - folate antagonist), Quinolones |
Catheter-Associated UTI (CAUTI)
- Change catheter before treating (biofilm issue).
- Treat only if symptomatic (fever, new confusion, suprapubic pain).
- 7 days antibiotics (guided by culture).
Recurrent UTI Prevention
Behavioural Measures
- High fluid intake.
- Post-coital voiding.
- Avoid spermicides.
- Wipe front to back.
Prophylaxis Options
| Strategy | Regimen | Notes |
|---|---|---|
| Continuous prophylaxis | Nitrofurantoin 50-100mg nocte | 6-12 months |
| Post-coital prophylaxis | Nitrofurantoin 50-100mg single dose | If sex-related |
| Self-start therapy | Patient-initiated 3-day course | For infrequent recurrence |
| Vaginal oestrogen | Topical cream/pessary | Postmenopausal women |
| Cranberry products | Juice or capsules | Limited evidence |
| Methenamine hippurate | 1g BD | For prophylaxis; avoid with nitrofurantoin |
Complications of UTI
| Complication | Risk Factors | Management |
|---|---|---|
| Pyelonephritis | Delayed treatment, obstruction | IV antibiotics, hydration |
| Renal abscess | Delayed treatment, structural abnormality | Drainage, prolonged antibiotics |
| Perinephric abscess | Extension of renal infection | Percutaneous drainage |
| Sepsis/Urosepsis | Obstruction, immunocompromise | Sepsis 6, ICU if severe |
| Renal scarring | Recurrent childhood UTI | Chronic kidney disease |
| Epididymo-orchitis | UTI in men | Prolonged antibiotics |
| Preterm labour | UTI in pregnancy | Close monitoring, treatment |
Antibiotic Resistance
- Rising resistance to trimethoprim (30-40% in some areas).
- ESBL-producing organisms increasing.
- Quinolone resistance increasing.
- Always check local resistance data.
Uncomplicated Cystitis
- Excellent prognosis.
- Symptoms resolve in 24-48 hours with treatment.
- Without treatment, 25-45% resolve spontaneously (but risk of progression).
Pyelonephritis
- Good prognosis if treated promptly.
- Mortality less than 1% in healthy adults.
- Higher risk with obstruction, diabetes, immunocompromise.
Recurrence Risk
- 25-30% of women have recurrence within 6 months.
- 3+ UTIs per year = recurrent UTI.
Long-Term Outcomes
- Uncomplicated UTI: No long-term sequelae.
- Recurrent pyelonephritis: Risk of renal scarring.
- Paediatric UTI: Investigate for VUR; risk of scarring.
Key Guidelines
| Guideline | Organisation | Key Recommendations |
|---|---|---|
| NICE NG109 | UK | Nitrofurantoin first-line, short course, no MSU for uncomplicated |
| NICE NG224 | UK | UTI in under 16s |
| SIGN 88 | Scotland | UTI management in adults |
| EAU Guidelines | Europe | Complicated UTI and pyelonephritis |
| IDSA Guidelines | USA | Uncomplicated cystitis and pyelonephritis |
Landmark Studies
1. IDSA Uncomplicated Cystitis Guidelines (2011) [7]
- Established trimethoprim-sulfamethoxazole (TMP-SMX) 3 days as benchmark.
- Nitrofurantoin 5 days equally effective.
- Fluoroquinolones reserved for resistance.
- Impact: Standardised treatment approach.
- PMID: 21292654.
2. Foxman et al. UTI Epidemiology (2000) [3]
- Characterised risk factors in young women.
- Sexual activity strongest modifiable risk factor in young women.
- PMID: 10809801.
3. Asymptomatic Bacteriuria Studies [4]
- Multiple RCTs show no benefit of treatment in elderly, diabetics, catheterised.
- Treatment only for pregnancy and pre-urological procedures.
- Impact: Reduced unnecessary antibiotic use.
- PMID: 16311099.
What is a UTI?
A urinary tract infection (UTI) is an infection caused by bacteria in any part of your urinary system - the kidneys, ureters, bladder, or urethra. Most UTIs affect the bladder (cystitis) and are easily treated with antibiotics.
Who Gets UTIs?
- Very common in women (1 in 2 will have one at some point).
- Less common in men, but can occur (especially with prostate problems).
- More common in pregnancy, diabetes, and with catheters.
What Are the Symptoms?
Bladder Infection (Cystitis)
- Burning or stinging when you urinate.
- Needing to urinate more often.
- Feeling like you need to go urgently.
- Pain in your lower tummy.
- Cloudy or smelly urine.
- Blood in urine.
Kidney Infection (Pyelonephritis)
- All of the above PLUS:
- High fever and chills.
- Pain in your side or back.
- Nausea and vomiting.
- Feeling very unwell.
How is it Diagnosed?
- Usually from your symptoms and a urine dipstick test.
- Sometimes a urine sample is sent to the lab.
How is it Treated?
- Antibiotics: Usually a short course (3 days for simple bladder infections).
- Drink plenty of fluids.
- Paracetamol: For pain and fever.
- Kidney infections: May need longer antibiotics or hospital treatment.
How Can I Prevent UTIs?
- Drink plenty of water.
- Don't hold on when you need to urinate.
- Wipe from front to back after using the toilet.
- Urinate after sex.
- Avoid perfumed products near the genital area.
- If you get frequent UTIs, talk to your doctor about prevention options.
When to Seek Urgent Help
- High fever or chills.
- Severe back or side pain.
- Vomiting and unable to keep fluids down.
- Blood in urine with fever.
- Symptoms not improving after 48 hours of antibiotics.
- Confused or very drowsy (especially elderly).
Primary Sources
- Flores-Mireles AL, et al. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13:269-284. PMID: 25853778.
- Foxman B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am. 2014;28:1-13. PMID: 24484571.
- Foxman B. Epidemiology of urinary tract infections. Clin Infect Dis. 2000;32:13-22. PMID: 10809801.
- Nicolle LE, et al. Infectious Diseases Society of America Guidelines for the Diagnosis and Treatment of Asymptomatic Bacteriuria in Adults. Clin Infect Dis. 2005;40:643-654. PMID: 15714408.
- NICE Guideline NG109. Urinary tract infection (lower): antimicrobial prescribing. 2018. https://www.nice.org.uk/guidance/ng109.
- NICE Guideline NG135. Urinary tract infection in pregnancy. 2018.
- Gupta K, et al. International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women. Clin Infect Dis. 2011;52:e103-e120. PMID: 21292654.
Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances. Always consult appropriate specialists.